The Cell & Gene Meeting on the Mesa takes place in Phoenix this year and is the sector’s foremost annual conference. It brings together executives and decision-makers in the industry to advance cutting-edge research in the cell and gene therapy sector today. Register to attend here.

Meet & greet with the Invest in Holland team

Meet with the Invest in Holland Life Sciences & Health team at Cell & Gene Meeting on the Mesa, October 7-9! We’d be happy to start the conversation on topics related to cell and gene therapy business opportunities in the Netherlands. Please reach out to us via PartneringONE to request in-person or virtual 1-on-1 meetings with us. You can also contact us directly: Brechtje Stallmann and Jan Zuidema.

The Netherlands provides excellent opportunities for cell and gene therapy companies

In the last two years several foreign companies have established European cell therapy manufacturing and R&D facilities in the Netherlands, including Kite, Fujifilm Irvine Scientific and Bristol Myers Squibb (BMS). The Netherlands’ high concentration of world-leading research talent, its business-oriented R&D facilities, startups and multinationals, and a supportive government, all make the Netherlands an attractive country for cell and gene therapy companies.

Choose the Netherlands for your clinical trials

The Netherlands is a European leader in clinical research and a hotspot for innovation in the life sciences and health sector. Home to top institutions, a high volume of trial initiations and among the most researchers per capita in Europe, the Netherlands offers a wealth of opportunity for sponsors and clinical researchers. Read more in our blog or download the NFIA folder Clinical Research.

✍️ Sign up for our newsletter to stay connected.